Regenxbio Inc (RGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -111,250 | -94,733 | 99,937 | -73,169 | -62,967 |
| Depreciation Amortization | 9,490 | 5,956 | 4,737 | 4,501 | 2,548 |
| Accounts receivable | -9,898 | -8,622 | -16,803 | 561 | 1,073 |
| Accounts payable and accrued liabilities | 3,873 | 1,528 | -218 | 2,621 | 186 |
| Other Working Capital | 14,219 | -5,325 | -7,774 | 897 | 5,229 |
| Other Operating Activity | 39,505 | -6,509 | 24,769 | 6,597 | 5,373 |
| Operating Cash Flow | $-54,061 | $-107,705 | $104,648 | $-57,992 | $-48,558 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 147,341 | 105,279 | -266,080 | 2,370 | 27,537 |
| PPE Investments | -26,869 | -11,720 | -13,278 | -7,160 | -8,149 |
| Sale Of Investment | 2,287 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $122,759 | $93,559 | $-279,358 | $-4,790 | $19,388 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7,422 | 8,376 | 205,062 | 85,043 | 179 |
| Other Financing Activity | 192,792 | 0 | -619 | -445 | -60 |
| Financing Cash Flow | $200,214 | $8,376 | $204,443 | $84,598 | $119 |
| Beginning Cash Position | 70,844 | 76,614 | 46,881 | 25,065 | 54,116 |
| End Cash Position | 339,756 | 70,844 | 76,614 | 46,881 | 25,065 |
| Net Cash Flow | $268,912 | $-5,770 | $29,733 | $21,816 | $-29,051 |
| Free Cash Flow | |||||
| Operating Cash Flow | -54,061 | -107,705 | 104,648 | -57,992 | -48,558 |
| Capital Expenditure | -26,869 | -11,720 | -13,278 | -7,160 | -8,149 |
| Free Cash Flow | -80,930 | -119,425 | 91,370 | -65,152 | -56,707 |